| 000 | 01623 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518041911.0 | ||
| 264 | 0 | _c20191121 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a2241-6293 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Baoyu | |
| 245 | 0 | 0 |
_aA study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway. _h[electronic resource] |
| 260 |
_bJournal of B.U.ON. : official journal of the Balkan Union of Oncology _c |
||
| 300 |
_a739-745 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aAutophagy _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSirolimus _xpharmacology |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xgenetics |
| 700 | 1 | _aYang, Jingbo | |
| 700 | 1 | _aLu, Zenghong | |
| 700 | 1 | _aLiu, Bin | |
| 700 | 1 | _aLiu, Fangzhou | |
| 773 | 0 |
_tJournal of B.U.ON. : official journal of the Balkan Union of Oncology _gvol. 24 _gno. 2 _gp. 739-745 |
|
| 999 |
_c29728811 _d29728811 |
||